Members Congress Loading Johnson: A Retail Investor Guide
Retail investors often wonder if congressional trades offer investing clues. This guide explains what "members congre...
Johnson & Johnson
On this tag page, you will find four Johnson & Johnson articles covering dividends, growth paths, and valuation targets. Learn how these insights can shape smarter, cost-aware investing.
10 articlesWhy Johnson Johnson, Altria, Verizon Stocks Climbed Today
When the AI rally paused, investors turned to dependable dividend names. Johnson Johnson, Altria, and Verizon led gai...
Pharma Momentum Fuels Johnson & Johnson Stock Rally
Johnson & Johnson shares jump as the company pushes through a resilient oncology lineup and strategic investments, li...
Smart Money Fleeing Tech: JNJ Stands Out in Turmoil
As technology stocks dominate the market, smart money fleeing tech may seek ballast in Johnson & Johnson. This articl...
Will Johnson & Johnson Stock Reach $300 This Year?
With Johnson & Johnson stock hovering near mid-230s, investors are weighing if a $300 target is in reach this year as...
Johnson Johnson Hopes Dethrone AbbVie’s Growth Driver
Two pharma giants are wighting for a leadership position in immunology. This piece explains why Johnson Johnson hopes...
Johnson Johnson Might Smartest Dividend King to Buy Now
In a market hungry for steady income and downside protection, Johnson & Johnson stands out as a potential smartest Di...
Two Distinct Growth Paths: Johnson & Johnson vs AbbVie
Johnson & Johnson and AbbVie report strong Q1 2026 results, showcasing two contrasting growth paths as biosimilar cha...
Analyst Thinks Johnson & Johnson Could Hit a $280 Target
A major analyst raises the price target on Johnson & Johnson to $280, arguing growing oncology sales and a planned sp...
Verizon vs Johnson & Johnson: Which Dividend Hike Wins?
Verizon raises its dividend with a high yield, while Johnson & Johnson offers steadier growth and a long payout histo...